477 related articles for article (PubMed ID: 30662405)
41. Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain.
Chen H; Qi X; Faulkner RA; Schumacher MM; Donnelly LM; DeBose-Boyd RA; Li X
Nat Commun; 2022 Jul; 13(1):4273. PubMed ID: 35879350
[TBL] [Abstract][Full Text] [Related]
42. Intestinal Deletion of 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Promotes Expansion of the Resident Stem Cell Compartment.
Doerfler AM; Han J; Jarrett KE; Tang L; Jain A; Saltzman A; De Giorgi M; Chuecos M; Hurley AE; Li A; Morand P; Ayala C; Goodlett DR; Malovannaya A; Martin JF; de Aguiar Vallim TQ; Shroyer N; Lagor WR
Arterioscler Thromb Vasc Biol; 2022 Apr; 42(4):381-394. PubMed ID: 35172604
[TBL] [Abstract][Full Text] [Related]
43. Tumor-specific expression of HMG-CoA reductase in a population-based cohort of breast cancer patients.
Gustbée E; Tryggvadottir H; Markkula A; Simonsson M; Nodin B; Jirström K; Rose C; Ingvar C; Borgquist S; Jernström H
BMC Clin Pathol; 2015; 15():8. PubMed ID: 26109908
[TBL] [Abstract][Full Text] [Related]
44. Effects of farnesyl pyrophosphate accumulation on calvarial osteoblast differentiation.
Weivoda MM; Hohl RJ
Endocrinology; 2011 Aug; 152(8):3113-22. PubMed ID: 21586555
[TBL] [Abstract][Full Text] [Related]
45. Rapid proteasomal elimination of 3-hydroxy-3-methylglutaryl-CoA reductase by interferon-γ in primary macrophages requires endogenous 25-hydroxycholesterol synthesis.
Lu H; Talbot S; Robertson KA; Watterson S; Forster T; Roy D; Ghazal P
Steroids; 2015 Jul; 99(Pt B):219-29. PubMed ID: 25759117
[TBL] [Abstract][Full Text] [Related]
46. Explication of interactions between HMGCR isoform 2 and various statins through In silico modeling and docking.
Karthik MV; Satya Deepak MV; Shukla P
Comput Biol Med; 2012 Feb; 42(2):156-63. PubMed ID: 22177940
[TBL] [Abstract][Full Text] [Related]
47. Mevalonate deprivation mediates the impact of lovastatin on the differentiation of murine 3T3-F442A preadipocytes.
Elfakhani M; Torabi S; Hussein D; Mills N; Verbeck GF; Mo H
Exp Biol Med (Maywood); 2014 Mar; 239(3):293-301. PubMed ID: 24477821
[TBL] [Abstract][Full Text] [Related]
48. Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms.
Fatehi Hassanabad A
Transl Lung Cancer Res; 2019 Oct; 8(5):692-699. PubMed ID: 31737505
[TBL] [Abstract][Full Text] [Related]
49. Statins are potential anticancerous agents (review).
Altwairgi AK
Oncol Rep; 2015 Mar; 33(3):1019-39. PubMed ID: 25607255
[TBL] [Abstract][Full Text] [Related]
50. Developmental processes regulated by the 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR) pathway: highlights from animal studies.
Eisa-Beygi S; Ekker M; Moon TW; Macdonald RL; Wen XY
Reprod Toxicol; 2014 Jul; 46():115-20. PubMed ID: 24732207
[TBL] [Abstract][Full Text] [Related]
51. Mevalonate Pathway and Human Cancers.
Bathaie SZ; Ashrafi M; Azizian M; Tamanoi F
Curr Mol Pharmacol; 2017; 10(2):77-85. PubMed ID: 26758953
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of Adenosine Monophosphate-Activated Protein Kinase-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Signaling Leads to Hypercholesterolemia and Promotes Hepatic Steatosis and Insulin Resistance.
Loh K; Tam S; Murray-Segal L; Huynh K; Meikle PJ; Scott JW; van Denderen B; Chen Z; Steel R; LeBlond ND; Burkovsky LA; O'Dwyer C; Nunes JRC; Steinberg GR; Fullerton MD; Galic S; Kemp BE
Hepatol Commun; 2019 Jan; 3(1):84-98. PubMed ID: 30619997
[TBL] [Abstract][Full Text] [Related]
53. Transcriptional and posttranscriptional inhibition of HMGCR and PC biosynthesis by geraniol in 2 Hep-G2 cell proliferation linked pathways.
Crespo R; Montero Villegas S; Abba MC; de Bravo MG; Polo MP
Biochem Cell Biol; 2013 Jun; 91(3):131-9. PubMed ID: 23668785
[TBL] [Abstract][Full Text] [Related]
54. Peroxisome proliferator-activated receptor γ down-regulation mediates the inhibitory effect of d-δ-tocotrienol on the differentiation of murine 3T3-F442A preadipocytes.
Torabi S; Yeganehjoo H; Shen CL; Mo H
Nutr Res; 2016 Dec; 36(12):1345-1352. PubMed ID: 27884413
[TBL] [Abstract][Full Text] [Related]
55. Peroxisomal Localization of a Truncated HMG-CoA Reductase under Low Cholesterol Conditions.
Wang J; Kunze M; Villoria-González A; Weinhofer I; Berger J
Biomolecules; 2024 Feb; 14(2):. PubMed ID: 38397481
[TBL] [Abstract][Full Text] [Related]
56. Pleiotropic use of Statins as non-lipid-lowering drugs.
Zhang Q; Dong J; Yu Z
Int J Biol Sci; 2020; 16(14):2704-2711. PubMed ID: 33110390
[TBL] [Abstract][Full Text] [Related]
57. Luciferase-based HMG-CoA reductase degradation assay for activity and selectivity profiling of oxy(lano)sterols.
Sagimori I; Yoshioka H; Hashimoto Y; Ohgane K
Bioorg Med Chem; 2020 Feb; 28(3):115298. PubMed ID: 31902650
[TBL] [Abstract][Full Text] [Related]
58. Perillyl alcohol and genistein differentially regulate PKB/Akt and 4E-BP1 phosphorylation as well as eIF4E/eIF4G interactions in human tumor cells.
Peffley DM; Sharma C; Hentosh P; Buechler RD
Arch Biochem Biophys; 2007 Sep; 465(1):266-73. PubMed ID: 17601486
[TBL] [Abstract][Full Text] [Related]
59. Synergistic inhibitory effect of apomine and lovastatin on osteosarcoma cell growth.
Moriceau G; Roelofs AJ; Brion R; Redini F; Ebetion FH; Rogers MJ; Heymann D
Cancer; 2012 Feb; 118(3):750-60. PubMed ID: 21751201
[TBL] [Abstract][Full Text] [Related]
60. The Mevalonate Pathway, a Metabolic Target in Cancer Therapy.
Guerra B; Recio C; Aranda-Tavío H; Guerra-Rodríguez M; García-Castellano JM; Fernández-Pérez L
Front Oncol; 2021; 11():626971. PubMed ID: 33718197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
